Drugs Affecting Blood and Blood Formation Practice Questions

Q: A female patient with a mechanical heart valve who is taking warfarin informs you that she hopes to get pregnant in the near future. What advice do you give her regarding her antithrombotic medication during the anticipated pregnancy?

Replace warfarin with heparin.. ### Explanation **1. Why the correct answer is right:** Warfarin is a small, lipid-soluble molecule that easily crosses the placenta. It is highly **teratogenic**, especially during the first trimester (6th–9th week), leading to **Fetal Warfarin Syndrome** (characterized by nasal hypoplasia, stippled epiphyses, and CNS defects). In contrast, **Heparin** (both Unfractionated Heparin and LMWH) is a large, polar molecule that **does not cross the placenta** and is therefore safe for the fetus. For patients with mechanical heart valves, anticoagulation must be maintained throughout pregnancy to prevent valve thrombosis, making heparin the safest substitute. **2. Why the incorrect options are wrong:** * **Option A:** Continuing warfarin until the third trimester exposes the fetus to the highest risk of malformations in the first trimester and intracranial hemorrhage during labor in the third trimester. * **Option B:** Aspirin at analgesic doses is not a substitute for anticoagulation in mechanical valves and can cause premature closure of the *ductus arteriosus*. * **Option C:** Discontinuing all medications is life-threatening for the mother, as pregnancy is a hypercoagulable state; a mechanical valve without anticoagulation will almost certainly thrombose. **3. Clinical Pearls for NEET-PG:** * **Fetal Warfarin Syndrome:** Look for keywords like "Chondrodysplasia punctata" or "stippled epiphyses." * **LMWH vs. UFH:** LMWH (e.g., Enoxaparin) is generally preferred in pregnancy due to a lower risk of Heparin-Induced Thrombocytopenia (HIT) and osteoporosis, but it requires monitoring of **Factor Xa levels**. * **The "Switch":** Common practice involves switching to Heparin before conception or as soon as pregnancy is confirmed, though some guidelines allow warfarin between 13–36 weeks if the dose is low (<5mg/day). However, for MCQ purposes, **Heparin is the drug of choice in pregnancy.**

Q: Which of the following laboratory tests is monitored in a patient receiving coumarin (warfarin) therapy?

Prothrombin time (PT). **Explanation:** **Warfarin (Coumarin)** is an oral anticoagulant that acts as a Vitamin K antagonist. It inhibits the enzyme **Vitamin K Epoxide Reductase (VKOR)**, preventing the γ-carboxylation of Vitamin K-dependent clotting factors: **II, VII, IX, and X**, as well as proteins C and S. **Why Prothrombin Time (PT) is the correct answer:** The PT measures the integrity of the **Extrinsic and Common pathways**. Factor VII has the shortest half-life (~6 hours) among the clotting factors, making it the first to decline during warfarin therapy. Therefore, PT is highly sensitive to warfarin’s effects. In clinical practice, PT is standardized as the **International Normalized Ratio (INR)** to ensure consistent monitoring across laboratories. **Why other options are incorrect:** * **A. Partial Thromboplastin Time (PTT/aPTT):** This test monitors the **Intrinsic pathway** and is primarily used to monitor **Unfractionated Heparin** therapy. * **B. Bleeding Time (BT):** This measures **platelet function** and vascular integrity, not the coagulation cascade. It is prolonged in conditions like von Willebrand disease or aspirin use. * **C. Capillary Fragility Test (CFT):** Also known as the Hess test, it assesses capillary resistance and is used to evaluate platelet deficiency or vascular disorders (e.g., Dengue). **High-Yield Clinical Pearls for NEET-PG:** * **Target INR:** Usually **2.0–3.0** for most conditions (e.g., Atrial Fibrillation, DVT). * **Warfarin-Induced Skin Necrosis:** Caused by a rapid decline in Protein C (short half-life), leading to a transient hypercoagulable state. * **Teratogenicity:** Warfarin is contraindicated in pregnancy (causes **Fetal Warfarin Syndrome**); Heparin is the drug of choice. * **Antidote:** For immediate reversal, use **Fresh Frozen Plasma (FFP)** or Prothrombin Complex Concentrate (PCC); for non-emergency reversal, use **Vitamin K1**.

Q: What is the longest-acting erythropoietin analogue?

Darbepoetin. **Explanation:** **Darbepoetin alfa** is the correct answer because it is a genetically engineered erythropoiesis-stimulating agent (ESA) designed for a significantly longer half-life compared to recombinant human erythropoietin (e.g., Epoetin α). The underlying medical concept is **glycosylation**. While Epoetin α has 3 N-linked carbohydrate chains, Darbepoetin has **5 N-linked chains**. This increased carbohydrate content decreases its affinity for the erythropoietin receptor but significantly reduces its clearance. Consequently, Darbepoetin has a half-life of approximately **24–26 hours** (about 3 times longer than Epoetin α), allowing for weekly or bi-weekly dosing instead of thrice-weekly. **Analysis of Incorrect Options:** * **A & B (Epoetin α and β):** These are recombinant human erythropoietins with identical amino acid sequences to endogenous erythropoietin. They have a short half-life (4–8 hours) and require frequent administration (usually 3 times a week). * **D (Romiplostim):** This is a **thrombopoietin receptor agonist** (TPO mimetic) used to treat immune thrombocytopenic purpura (ITP). It stimulates platelet production, not red blood cells. **NEET-PG High-Yield Pearls:** * **Methoxy polyethylene glycol-epoetin beta (CERA):** If mentioned, this is a "Continuous Erythropoietin Receptor Activator" with an even longer half-life (~130 hours), allowing for once-monthly dosing. * **Side Effects:** The most common side effect of ESAs is **hypertension** and increased risk of **thrombotic events** (stroke/MI). * **Indication:** Primarily used in anemia due to Chronic Kidney Disease (CKD) and chemotherapy-induced anemia. Target hemoglobin should not exceed 11–12 g/dL to avoid toxicity.

Q: Which of the following statements about Dabigatran is true?

Idarucizumab is a reversal agent for dabigatran.. **Explanation:** **Dabigatran** is a Direct Thrombin Inhibitor (DTI) that binds directly to the active site of both free and clot-bound thrombin (Factor IIa) [1, 2]. 1. **Why Option C is Correct:** **Idarucizumab** is a humanized monoclonal antibody fragment designed specifically to reverse the anticoagulant effects of dabigatran. It binds to dabigatran with an affinity 350 times higher than that of thrombin, neutralizing it immediately. This is a high-yield fact for emergencies like life-threatening bleeding or urgent surgery. 2. **Why Other Options are Incorrect:** * **Option A:** Dabigatran is a **Direct Thrombin (Factor IIa) inhibitor**, not a Factor Xa inhibitor [1]. Drugs like Rivaroxaban and Apixaban are Factor Xa inhibitors. * **Option B:** Dabigatran is unique among NOACs because it is **primarily excreted by the kidneys (~80%)**. Therefore, it is contraindicated in patients with severe renal impairment (CrCl <30 mL/min) [1]. * **Option D:** Dabigatran, like most New Oral Anticoagulants (NOACs), is significantly **more expensive** than traditional anticoagulants like Warfarin. **Clinical Pearls for NEET-PG:** * **Mechanism:** Direct Thrombin Inhibitor (DTI) [1, 2]. * **Prodrug:** Dabigatran etexilate is a prodrug converted by esterases in the gut and liver [1, 2]. * **Monitoring:** Routine monitoring (like PT/INR) is not required [2]; however, **aPTT** or Ecarin Clotting Time (ECT) can be used to assess its effect if necessary. * **Storage:** It is highly sensitive to moisture and must be kept in its original blister packaging. * **Other DTIs:** Lepirudin, Desirudin, Bivalirudin (Parenteral); Argatroban (used in HIT).

Q: Ticlopidine acts by which mechanism?

Decreasing ADP mediated cAMP activation. **Explanation:** **Mechanism of Action (Why A is correct):** Ticlopidine is a first-generation **Thienopyridine** antiplatelet agent. It acts as an irreversible antagonist of the **P2Y12 receptor**, which is a G-protein coupled receptor for ADP on the platelet surface. Normally, ADP binding to P2Y12 inhibits adenylyl cyclase, leading to a decrease in intracellular cAMP. By blocking this receptor, Ticlopidine prevents the ADP-mediated suppression of cAMP. Consequently, **cAMP levels remain elevated**, which inhibits platelet activation and the subsequent expression of GP IIb/IIIa receptors, preventing fibrinogen binding and platelet aggregation. **Analysis of Incorrect Options:** * **Option B:** This describes the mechanism of **Aspirin**, which causes irreversible inhibition of the Cyclooxygenase-1 (COX-1) enzyme, thereby blocking Thromboxane A2 (TXA2) synthesis. * **Option C:** This refers to drugs like **Abciximab, Eptifibatide, and Tirofiban**, which directly block the Glycoprotein IIb/IIIa receptor, the "final common pathway" for platelet aggregation. **NEET-PG High-Yield Pearls:** 1. **The Thienopyridine Family:** Includes Ticlopidine, Clopidogrel, and Prasugrel. All are **prodrugs** and act irreversibly on P2Y12. (Note: Ticagrelor is a non-thienopyridine and acts reversibly). 2. **Adverse Effects:** Ticlopidine is rarely used today due to severe hematological toxicities, specifically **Neutropenia/Agranulocytosis** and **Thrombotic Thrombocytopenic Purpura (TTP)**. 3. **Monitoring:** Frequent CBC monitoring is required during the first 3 months of Ticlopidine therapy. Clopidogrel is preferred clinically due to a better safety profile.

Q: A patient has subclinical folate deficiency. All of the following drugs can precipitate megaloblastic anemia in this patient except?

Chloroquine. **Explanation:** The correct answer is **Chloroquine**. Megaloblastic anemia is primarily caused by a deficiency or impaired utilization of **Folic acid (Vitamin B9)** or **Vitamin B12**, both of which are essential for DNA synthesis. **Why Chloroquine is the correct answer:** Chloroquine is an antimalarial and anti-inflammatory drug that does not interfere with folate metabolism, absorption, or DNA synthesis. Therefore, it does not precipitate megaloblastic anemia, even in patients with subclinical deficiency. **Why the other options are incorrect:** * **Alcohol:** Chronic alcohol consumption is a common cause of folate deficiency. It interferes with the enterohepatic circulation of folate, inhibits its absorption in the jejunum, and has a direct toxic effect on the bone marrow. * **Phenytoin:** This anticonvulsant reduces folate levels by inhibiting the enzyme intestinal conjugase (preventing absorption) and by inducing hepatic enzymes that increase folate catabolism. Long-term use frequently leads to subclinical folate deficiency. * **Sulfasalazine:** Used in inflammatory bowel disease, it acts as a competitive inhibitor of the reduced folate carrier (RFC), significantly impairing the intestinal absorption of dietary folate. **NEET-PG High-Yield Pearls:** 1. **DHFR Inhibitors:** Drugs like **Methotrexate, Pyrimethamine, and Trimethoprim** are classic causes of megaloblastic anemia as they inhibit Dihydrofolate Reductase. 2. **DNA Synthesis Inhibitors:** **5-Fluorouracil, Hydroxyurea, and Zidovudine (AZT)** can cause megaloblastic changes without necessarily lowering folate levels. 3. **Oral Contraceptives:** Can occasionally interfere with folate absorption. 4. **Management:** When treating megaloblastic anemia caused by DHFR inhibitors, **Folinic acid (Leucovorin)** is preferred over Folic acid to bypass the inhibited enzyme.

Q: A patient receiving coumarin therapy for three years recently developed a bleeding tendency. How will you reverse the effect of coumarin therapy?

Vitamin K injection. **Explanation:** **Mechanism of Action & Correct Answer:** Coumarin derivatives (like Warfarin) are oral anticoagulants that act as **Vitamin K antagonists**. They inhibit the enzyme **Vitamin K Epoxide Reductase (VKOR)**, preventing the conversion of inactive Vitamin K epoxide to its active hydroquinone form. This results in the depletion of active Vitamin K, which is essential for the γ-carboxylation (activation) of clotting factors **II, VII, IX, and X**. Therefore, the physiological and direct pharmacological antidote to reverse coumarin-induced bleeding is **Vitamin K injection** (Phytonadione), which bypasses the inhibition and restores clotting factor synthesis. **Analysis of Incorrect Options:** * **A. Protamine injection:** This is the specific antidote for **Heparin** overdose. It is a basic protein that neutralizes acidic heparin through ionic bonding. * **C. Infusion of fibrinogen:** Fibrinogen (Factor I) is used in specific deficiency states or DIC, but it does not address the multi-factor deficiency (II, VII, IX, X) caused by coumarins. * **D. Whole blood transfusion:** While it can replace volume, it is not the standard of care for reversing anticoagulation. If immediate reversal is required (life-threatening bleed), **Fresh Frozen Plasma (FFP)** or **Prothrombin Complex Concentrate (PCC)** is preferred over whole blood. **NEET-PG High-Yield Pearls:** * **Immediate Reversal:** Vitamin K takes 6–24 hours to work (requires new protein synthesis). For **emergency** reversal, use **FFP** or **PCC**. * **Monitoring:** Warfarin therapy is monitored using **PT/INR** (Extrinsic pathway). * **Teratogenicity:** Warfarin is contraindicated in pregnancy (causes Fetal Warfarin Syndrome); Heparin is the anticoagulant of choice for pregnant women.

Question 1

A patient with atherosclerosis requires prevention of stroke. Which of the following is the most beneficial drug for this purpose?

Accepted Answer

Aspirin

Answer

Warfarin

Answer

Low dose subcutaneous heparin

Answer

Digoxin

Question 2

A female patient with a mechanical heart valve who is taking warfarin informs you that she hopes to get pregnant in the near future. What advice do you give her regarding her antithrombotic medication during the anticipated pregnancy?

Accepted Answer

Replace warfarin with heparin.

Answer

Continue with warfarin until the third trimester.

Answer

Replace warfarin with aspirin at analgesic doses.

Answer

Discontinue all medications that affect the blood.

Question 3

Which of the following laboratory tests is monitored in a patient receiving coumarin (warfarin) therapy?

Accepted Answer

Prothrombin time (PT)

Answer

Partial thromboplastin time (PTT)

Answer

Bleeding time (BT)

Answer

Capillary fragility test (CFT)

Question 4

What is the longest-acting erythropoietin analogue?

Accepted Answer

Darbepoetin

Answer

Epoietin α

Answer

Epoietin β

Answer

Romiplostim

Question 5

Which of the following statements about Dabigatran is true?

Accepted Answer

Idarucizumab is a reversal agent for dabigatran.

Answer

Dabigatran is a Factor Xa inhibitor.

Answer

Dabigatran is primarily excreted by the liver.

Answer

Dabigatran is an inexpensive anticoagulant.

Question 6

Decreased effect of warfarin is seen in which of the following conditions?

Accepted Answer

Nephrotic syndrome

Answer

Acute intake of alcohol

Answer

Concurrent treatment with phenylbutazone

Answer

Congestive heart failure

Question 7

Ticlopidine acts by which mechanism?

Accepted Answer

Decreasing ADP mediated cAMP activation

Answer

Decreasing COX enzyme irreversibly

Answer

Gp IIb/IIIa antagonist

Answer

None of the above

Question 8

Which of the following statements about pegfilgrastim is true?

Accepted Answer

It decreases the risk of neutropenia in patients on anti-cancer therapy.

Answer

It is a short-acting drug.

Answer

It can be given orally.

Answer

It is recombinant G-CSF.

Question 9

A patient has subclinical folate deficiency. All of the following drugs can precipitate megaloblastic anemia in this patient except?

Accepted Answer

Chloroquine

Answer

Alcohol

Answer

Phenytoin

Answer

Sulfasalazine

Question 10

A patient receiving coumarin therapy for three years recently developed a bleeding tendency. How will you reverse the effect of coumarin therapy?

Accepted Answer

Vitamin K injection

Answer

Protamine injection

Answer

Infusion of fibrinogen

Answer

Whole blood transfusion

Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation — MCQs

On this page

Practice by Chapter

Want unlimited practice?